About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Follicular Lymphoma - Bendamustine and Rituximab as Preferred Treatment and Maintenance Therapy
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Mathias J. Rummel
By
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
FEATURING
Mathias J. Rummel
0 views
October 25, 2018
Comments
0
Login to view comments.
Click here to Login
Featured Video
16:51
Incyte
Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk
Feat.
C. Harrison
Featured Video
16:26
Incyte
Effects of a Treatment Option on Hematocrit Control and Spleen Volum…
Feat.
C. Harrison
Recommended
AUTOPLAY
ON
Related
Newest
16:57
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Lymphoma Highlights"
Feat.
B. D. Cheson
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
27:51
Louisville Hematology Highlights
Summary of Recent Advances in Follicular Lymphoma
Feat.
S. Gaballa
13:56
SOHO 2023 Eleventh Annual Meeting
Follicular Lymphoma Management: What Is the New Order?
Feat.
B. Kahl
18:24
Memorial Sloan Kettering Cancer Center
Key Lymphoma Updates From ASH
Feat.
P. Torka
19:20
Mitchell Smith
Treatment Landscape in Follicular Lymphoma
25:23
Indy Hematology Review
When Not to Watch and Wait: Emerging Strategies in the Treatment of …
Feat.
M. Williams
15:32
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Current Clinical Management of Follicular Lymphoma
Feat.
B. Ferhanoğlu
14:34
Northwestern Medicine Oncology and Hematology
EZH2 Inhibition in FL: Overview and Analysis of the SYMPHONY-1 Trial
Feat.
L. Gordon
13:58
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Intrathecal Rituximab + Dex for Refractory Sanctu…
Feat.
M. Salamoon
26:25
Yale Cancer Center
Yale Cancer Center Updates on B-Cell Lymphomas: Exploring MCL, DLBCL…
Feat.
S. Kothari
27:49
MyCancerHaven
Overview of the Diagnosis and Treatment of Follicular Lymphoma
Feat.
R. Vij,
T. Fehniger
15:08
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Sequencing Therapy in Indolent Lymphoma - Treatment Choic…
Feat.
L. Nastoupil
17:19
SOHO Turkey 2023
SOHO Turkey 2023: How I Treat Follicular Lymphoma
Feat.
J. Lister
15:11
Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies
Lymphoma Bispecific Antibody Therapy and Management of CRS
Feat.
D. Land,
M. Hughes
14:36
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
The Latest Data on New Therapies in FL and MZL
Feat.
J. Carter
11:12
SOHO 2023 Eleventh Annual Meeting
SOHO 2023 Next Questions: Indolent B-Cell Lymphoma
Feat.
L. Nastoupil
09:10
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Acalabrutinib Added to Lenalidomide & R…
Feat.
P. Strati
36:10
University of Colorado Division of Hematology
2023 Denver ASH Review: Updates in CLL and Lymphoma
Feat.
A. Major
44:29
UChicago Medicine
Improving Lymphoma Outcomes: Optimizing Trial Design, Using Surrogat…
Feat.
A. Zelenetz
